Laura Onorato, PA
Physician Assistant · Santa Fe, NMNPI 1093809477
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,324 of the $6,754 with a category attached, or 78.8%. It is spread thinly across 27 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,014, more than ten times the $84 reported in 2019. Among physician assistant clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $64.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- Novo Nordisk$871
- AstraZeneca$675
- Astellas Pharma US Inc$418
- Amgen$371
- Boehringer Ingelheim$340
- plus $3K from 21 others
What the payments were for
- Consulting fees$1,08016%
- Food & beverage$5,32479%
- Education$3505%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 8 | $1,251 |
| Novo Nordisk | 24 | $871 |
| AstraZeneca | 7 | $675 |
| Astellas Pharma US Inc | 6 | $418 |
| Amgen | 4 | $371 |
| Boehringer Ingelheim | 9 | $340 |
| Johnson & Johnson(2 entities) | 4 | $305 |
| Lilly USA, LLC | 8 | $297 |
| GSK | 4 | $276 |
| Otsuka America Pharmaceutical, Inc. | 2 | $219 |
| Phathom Pharmaceuticals, Inc. | 2 | $217 |
| Incyte Corporation | 3 | $204 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $184 |
| AbbVie | 2 | $177 |
| Novartis | 2 | $154 |
| Bayer | 3 | $141 |
| Dexcom, Inc. | 2 | $126 |
| Blue Earth Diagnostics | 1 | $123 |
| Gilead | 1 | $105 |
| E.r. Squibb & Sons, L.L.C. | 1 | $75 |
| Regeneron Healthcare Solutions, Inc. | 1 | $50 |
| Sanofi | 2 | $45 |
| Abbott | 2 | $43 |
| Janssen Scientific Affairs, LLC | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,754 in reported general payments places this provider in the 95th percentile of 635 physician assistant providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 18 | $38,121 |
| JardianceEmpagliflozin | 14 | $15,473 |
| EliquisApixaban | 16 | $12,368 |
| TrulicityDulaglutide | 11 | $10,405 |
| Levothyroxine Sodium | 137 | $2,105 |
| Omeprazole | 56 | $943 |
| Losartan Potassium | 53 | $871 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $720 |
| Atorvastatin Calcium | 71 | $706 |
| Gabapentin | 46 | $702 |
| Lisinopril | 64 | $670 |
| Trazodone Hcl | 44 | $512 |
| Duloxetine Hcl | 17 | $507 |
| Tamsulosin Hcl | 28 | $425 |
| Estradiol | 11 | $418 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $27 | $38,12118 claims |
| Boehringer IngelheimJardiance | $340 | $15,47314 claims |
| PfizerEliquis | $1,251 | $12,36816 claims |
| Lilly USA, LLCTrulicity | $297 | $10,40511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 635 physician assistant providers in New Mexico.
Other physician assistant in Santa Fe
- Erin RayburnSanta Fe$25K
- Tonilyn HatchSanta Fe$3K
- Carolyn BauerSanta Fe$3K
- Loretta TorresSanta Fe$3K
- Darina LinnikSanta Fe$3K
- Leigh HigginsAlbuquerque$10K
- Maria AbeytaAlbuquerque$8K
- Kari LavigneAlbuquerque$8K
- Elizabeth BelitzAlbuquerque$8K
- Eric GriffinFarmington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.